PDF Cover

Corneal Refractive Therapy Crt Market

The market for Corneal Refractive Therapy Crt was estimated at $1.4 billion in 2025; it is anticipated to increase to $2.3 billion by 2030, with projections indicating growth to around $3.8 billion by 2035.

Report ID:DS1806026
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Other Healthcare
Corneal Refractive Therapy Crt
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Corneal Refractive Therapy Crt Market Outlook

Revenue, 2025

$1.4B

Forecast, 2035

$3.8B

CAGR, 2026 - 2035

10.4%

The Corneal Refractive Therapy Crt industry revenue is expected to be around $1.4 billion in 2026 and expected to showcase growth with 10.4% CAGR between 2026 and 2035. The findings highlighted the significance of the Corneal Refractive Therapy CRT industry to the global vision correction field with regard to refractive error management. This is due to an increase in the incidence of myopia and astigmatism and a preference by patients for non surgical treatments. The main uses of CRT at present are in the treatment of myopia and astigmatism, which combined account for 85.4% of the current usage of the technique. This highlights the position of CRT as a standard procedure for the treatment of astigmatism and the slowing down of myopia in adults and children alike. The overnight ortho k lenses market sector is the largest, accounting for $0.93 billion in revenue in the year 2025. This is due to contact lens technology improvements, more experienced eye care practitioners and the increased use of corneal mapping to help with lens fitting. Growing acceptance by eye specialists, covered insurance in some regions and its compatibility with an active lifestyle and safety concerns are factors which support the growth of corneal refractive therapy over lasers and conventional day time glasses as a reversible method of non surgical correction.

Orthokeratology with Corneal Refractive Therapy CRT provides customised orthokeratology contact lenses to reshape the cornea overnight. The reshaping of the cornea produces clear vision during the day without glasses or contact lenses. The reshaping is safely reversed each morning. Key features include customised lens geometry tailored from a precise map of the cornea, a high oxygen transmission rate which supports the long term functioning of the cornea and the lens compatibility with follow up diagnostic protocols and computerised monitoring equipment often incorporated into high tech eye examining machines. The main uses of this treatment are in relation to short sightedness and astigmatism, but there is a growing focus on how to prevent short sight developing in children as well as in cases where people are slightly long sighted or who have had previous eye surgery but do not only wish to undergo another operation. Growing demand for non invasive refractive correction procedures is driven by factors such as the rising attention from the medical profession on prevention of myopia in younger patients, rapidly evolving lens technologies and software design, and a rise in use of contact lenses by athletes and professionals, this has consolidated the position of this non invasive method as an alternative which is technologically advanced and patient orientated.

Corneal Refractive Therapy Crt market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Corneal Refractive Therapy Crt Market Outlook

Market Key Insights

  • The CRT sector is expected to be worth 3.8 billion U.S. dollars in 2035 and 1.4 billion U.S. dollars in 2025. The sector has grown at a compound annual growth rate of 10.4%. This is largely due to increasing demand in the fields of non surgical vision correction and child vision improvement.

  • This market is made up of a number of prominent players including Paragon Vision Sciences, Bausch & Lomb Inc., Menicon Co. Ltd., who are responsible for the competitive landscape that exists within the industry.

  • The U.S. and China dominate the global Corneal Refractive Therapy Crt market. Growth in the U.S. and Chinese markets is expected to experience 7.6 to 10.9% annual growth rates from 2025 to 2030.

  • Growing rapidly are economies such as India, Thailand and Saudi Arabia, which are expected to show a Compound Annual Growth Rate between 10 and 13% .

  • The adoption of non invasive treatments for corneal refractive therapy is expected to drive the Crt industry, leading to an additional $219 million by 2030.

  • The Corneal Refractive Therapy market is forecast to expand by $2.4 billion between 2025 and 2030, with manufacturers targeting ophthalmic clinics and home care applications for a larger share of the market.

  • The CRT market for corneal refractive therapy is expected to increase by 169% between 2025 and 2035, partly because of advancements in CRT technology. Myopia has been rising.

corneal refractive therapy crt market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Corneal Refractive Therapy Crt - Country Share Analysis

Opportunities in the Corneal Refractive Therapy Crt

With a growing number of working age people experiencing computer related eye strain symptoms, there is also a rising need for treatments which allow users to see without the need for surgery. The Corneal Refractive Therapy programme allows individuals to enjoy clear, unaided vision during working hours, without having to wear spectacles or conventional contact lenses during the day. Between 2025 and 2030, day time orthokeratology lenses are expected to increase from $0.50 billion to $0.73 billion at an annual growth rate of 7.99%. This of lens is especially useful for people in towns who are in white collar jobs and who have mild to moderate vision problems.

Growth Opportunities in North America and Asia Pacific

Demand for Corneal Refractive Therapy in North America is driven by growing patient numbers due to an awareness of non surgical vision correction procedures, increasing cases of myopia in children, plus a desire from patients to opt for orthokeratology or overnight vision correction over surgery; possible ways for growth include extending optometrists myopia management services to a wider client base, developing niche premium services for people who value a certain lifestyle, and using digital tools to allow remote check ups. The competitive market is highly competitive with the leading multinational contact lens suppliers concentrating on improved lens designs, practitioner education and selling products based on the benefits to the customer. This is especially true of the larger contact lens suppliers. New companies can differentiate themselves with safety profiles that are backed by data, special lenses for children and teenagers and close relationships with independent optometrists.
The Asia Pacific market for Corneal Refractive Therapy is being driven by a high incidence of myopia, rapid urbanisation and increasing purchasing power in this region. This provides opportunities in regionalised lens designs that have been tailored to suit the various corneal profiles prevalent in different region's, tiered products which cater to metropolitan and secondary cities, and partnerships with clinics which specialise in eye care for children as well as schools. Across the rapidly growing market for non surgical vision correction, it is crucial to have clinical evidence, after care support, education for medical practitioners and localised marketing. Regional companies which are agile, clinics that run their own labels and international brands are all competing in this market.

Market Dynamics and Supply Chain

01

Driver: Advancements in CRT Technology, and Growing Awareness and Acceptance

also advances in Corneal Refractive Therapy in orthokeratology are also driving the markets expansion. These progressions have also enhanced CRT as an effective and dependable method for improving vision without surgery leading to an increase, in patients choosing this non invasive treatment option. An increasing public awareness about the benefits and safety of corneal refractive therapy, coupled with a wider acceptance among eye specialists and healthcare providers, is also propelling the growth of the CRT market.
Myopia is also becoming more common worldwide. The demand for CRT is also rising as its seen as an effective treatment for the condition especially, in the Asia Pacific area.
02

Restraint: High Cost Implications

While Corneal Refractive Therapy has its advantages, a major obstacle hindering its market expansion is the cost linked to this treatment option. Insurance providers often view these procedures as expenses resulting in limited coverage, for individuals who could truly benefit from them. Since they are considered treatments patients are left with a significant financial strain making it challenging for many to access them.
03

Opportunity: Premium ophthalmology clinics in Asia-Pacific adopting Corneal Refractive Therapy Crt for advanced refractive error management and Rapidly expanding pediatric myopia control market using Corneal Refractive Therapy Crt overnight ortho-k lenses globally

The rapid increase in earnings and heavy pressure on students to perform well in the Asia Pacific region has created a high demand for eye care treatment which delays or puts off the necessity for eye surgery involving lasers. Many leading eye clinics are now including corneal refractive therapy and the latest Ortho K lenses in their overall eye care treatment options. Companies that work with lens suppliers in a strategic manner, use data to tailor lens prescriptions to a patients eye shape and provide follow up care via telecommunications have a competitive advantage. The strongest growth in this region is expected to be achieved by overnight ortho k lenses, especially in the cities of South Korea, China and those in Southeast Asia.
Growing at an alarming rate, the incidence of myopia in children is leading to a demand for myopia treatments in highly populated region's. CRT with overnight ortho k contact lenses provides a non surgical way to correct vision, allowing it to be a parental favourite because it is safe and can be used by children during school term. The overnight ortho k segment is predicted to rise from $0.93 billion in the year 2025 to $1.62 billion in 2030, with an annual growth rate of 11.6%. Growth will be particularly pronounced in the region of paediatric ophthalmology; this is especially so for children who are of school age and who need unaided vision all the time.
04

Challenge: Awareness and Knowledge Disparity

One obstacle hindering market expansion arises from a limited comprehension of CRT among prospective patients and healthcare practitioners alike. The advantages and methods of CRT are not only commonly recognized or grasped as conventional eye correction options such, as spectacles or contact lenses.

Supply Chain Landscape

1

Corneal Refractive Materials

Menicon Co. Ltd.Bausch & Lomb Inc
2

Orthokeratology Lens Manufacturing

Paragon Vision SciencesEuclid Systems Corporation
3

Therapy Crt Distribution

CooperVisionBausch & Lomb Inc
4

Overnight Vision Correction

optometry clinicsophthalmology centersmyopia management practices
Corneal Refractive Therapy Crt - Supply Chain

Use Cases of Corneal Refractive Therapy Crt in Non-Surgical Vision Correction & Pediatric Vision Improvement

Non-Surgical Vision Correction : Corneal Refractive Therapy is an alternative to surgical procedures for correcting vision problems such as nearsightedness or myopia by using specially designed contact lenses that reshape the cornea overnight instead of opting for surgeries like LASIK due to its non invasive approach and reversible nature without the associated surgical risks. Paragon Vision Sciences leads the market with its Paragon CRT lenses, in this field.
Pediatric Vision Improvement : In the realm of childrens eye care known as ophthalmology, Corneal Refractive Therapy has proven to be quite useful in slowing down the progression of nearsightedness in kids. It provides parents with an effective way to address their childrens vision issues early on. One standout feature is the absence of eyewear which helps alleviate worries about broken glasses or misplaced contact lenses. A key player, in this field Euclid Systems has taken steps by offering Orthokeratology lenses tailored specifically for young ones.

Recent Developments

Corneal Refractive Therapy a surgical technique intended to reshape the cornea overnight as one sleeps is increasingly gaining popularity, within the optical care industry market segment lately.

December 2024 : Paragon Vision Sciences introduced an update to their CRT lens product line aimed at enhancing comfort and efficacy, for individuals undergoing corneal refractive therapy.
October 2024 : Coopervision made a move by expanding into Asian markets with their cutting edge CRT products to cater to the increasing interest in non surgical vision correction, in the region.
July 2024 : A leading company, in the industry is Bausch & Lomb. They launched a cutting edge CRT lens technology that offers vision correction.

Impact of Industry Transitions on the Corneal Refractive Therapy Crt Market

As a core segment of the Other Healthcare industry, the Corneal Refractive Therapy Crt market develops in line with broader industry shifts. Over recent years, transitions such as Shift towards Non-Invasive Procedures and Technological Advancements in CRT have redefined priorities across the Other Healthcare sector, influencing how the Corneal Refractive Therapy Crt market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift towards Non-Invasive Procedures

Growing demand for less invasive procedures is significantly altering the way the Corneal Refractive Therapy market is shaping up, and this trend is leading to increased preference for non surgical vision correction techniques. By 2030, this trend is expected to result in a $219 million increase in market growth. With consumers opting for methods of refractive surgery that are convenient, reversible and low in risk, Corneal Refractive Therapy solutions are emerging as premium offerings for daytime spectacle freedom and overnight vision correction. These comprise CRT contact lenses of a more advanced and orthokeratology lenses. The move enhances the place of CRT in the treatment of myopia and extends its application beyond to the whole Corneal Refractive Therapy portfolio. It prompts practitioners to provide more treatment and educate patients better, thereby differentiating their service with non invasive treatments which have been clinically proven. These treatments cater for patients who can afford higher costs.
02

Technological Advancements in CRT

Current innovations are affecting the way treatments are performed for the condition known as CRT with wavefront and topography guided procedures enabling tailored and precise treatments.